» Articles » PMID: 14522917

Mislocalization of Membrane Proteins Associated with Multidrug Resistance in Cisplatin-resistant Cancer Cell Lines

Overview
Journal Cancer Res
Specialty Oncology
Date 2003 Oct 3
PMID 14522917
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

The accumulation of [(14)C]carboplatin and [(3)H]methotrexate is reduced in single-step KB epidermoid adenocarcinoma (KB-CP) cells, which are cross-resistant to carboplatin, methotrexate, and sodium arsenite. In these KB-CP cells, multidrug resistance is accompanied by mislocalization of multidrug resistance associated protein (MRP) 1 and other membrane proteins such as folate-binding protein. MRP1 was not decreased in amount in single-step variants but accumulates in a cytoplasmic fraction, and its apparent molecular weight was altered probably because of reduced glycosylation in resistant cells. This low-density compartment was partially labeled with antibodies to lectin-GSII (a Golgi marker) and Bip/GRP78 (an endoplasmic reticulum marker). Pulse-chase labeling of MRP1 with (35)S-methionine and (35)S-cysteine and pulse-chase biotinylation of cell surface MRP1 suggests that membrane protein mislocalization is caused mainly by a defect of plasma membrane protein recycling, manifested also as a defect in acidification of lysosomes. The reduced accumulation of cytotoxic compounds in the KB-CP cells is presumed to result from the failure of carrier proteins and/or transporters to localize to the plasma membrane.

Citing Articles

C1GALT1 expression predicts poor survival in osteosarcoma and is crucial for ABCC1 transporter-mediated doxorubicin resistance.

Liu C, Huang J, Chang H, Chen C, Tsai Y, Chen W J Pathol. 2025; 265(3):289-301.

PMID: 39844613 PMC: 11794964. DOI: 10.1002/path.6384.


Establishment and characterization of a multi-drug resistant cell line for canine mammary tumors.

Zhou C, Lin Z, Li X, Zhang D, Song P Front Vet Sci. 2023; 10:1129756.

PMID: 37077947 PMC: 10108679. DOI: 10.3389/fvets.2023.1129756.


CRISPR/Cas9-based genome-wide screening for deubiquitinase subfamily identifies USP1 regulating MAST1-driven cisplatin-resistance in cancer cells.

Tyagi A, Kaushal K, Chandrasekaran A, Sarodaya N, Das S, Park C Theranostics. 2022; 12(13):5949-5970.

PMID: 35966591 PMC: 9373805. DOI: 10.7150/thno.72826.


Is Autophagy Always a Barrier to Cisplatin Therapy?.

Xu J, Gewirtz D Biomolecules. 2022; 12(3).

PMID: 35327655 PMC: 8946631. DOI: 10.3390/biom12030463.


Different Ability of Multidrug-Resistant and -Sensitive Counterpart Cells to Release and Capture Extracellular Vesicles.

Sousa D, Lima R, Lopes-Rodrigues V, Gonzalez E, Royo F, Xavier C Cells. 2021; 10(11).

PMID: 34831110 PMC: 8616370. DOI: 10.3390/cells10112886.